<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004225.pub2" GROUP_ID="PREG" ID="619901041011432084" MERGED_FROM="" MODIFIED="2009-11-08 15:50:50 +0100" MODIFIED_BY="Sonja Henderson" NOTES="&lt;p&gt;Exported from Review Manager 4.2.2&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.2&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.2&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.2&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;Exported from Review Manager 4.2.2&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2009-10-28 10:10:43 +0000" NOTES_MODIFIED_BY="Jill V Hampson" REVIEW_NO="0359" REVMAN_SUB_VERSION="5.0.22" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2009-11-08 15:50:50 +0100" MODIFIED_BY="Sonja Henderson">
<TITLE>Exercise for diabetic pregnant women</TITLE>
<CONTACT MODIFIED="2009-11-08 15:50:50 +0100" MODIFIED_BY="Sonja Henderson"><PERSON ID="15857" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Gilles</FIRST_NAME><LAST_NAME>Ceysens</LAST_NAME><POSITION>Gynaecologist</POSITION><EMAIL_1>gceysens@ulb.ac.be</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>Ambroise Pare hospital</ORGANISATION><ADDRESS_1>Bd Kennedy, 2</ADDRESS_1><CITY>Mons</CITY><ZIP>7000</ZIP><COUNTRY CODE="BE">Belgium</COUNTRY><PHONE_1>003265393781</PHONE_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2009-11-08 15:50:50 +0100" MODIFIED_BY="Sonja Henderson"><PERSON ID="15857" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Gilles</FIRST_NAME><LAST_NAME>Ceysens</LAST_NAME><POSITION>Gynaecologist</POSITION><EMAIL_1>gceysens@ulb.ac.be</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>Ambroise Pare hospital</ORGANISATION><ADDRESS_1>Bd Kennedy, 2</ADDRESS_1><CITY>Mons</CITY><ZIP>7000</ZIP><COUNTRY CODE="BE">Belgium</COUNTRY><PHONE_1>003265393781</PHONE_1></ADDRESS></PERSON><PERSON ID="16008" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Dominique</FIRST_NAME><LAST_NAME>Rouiller</LAST_NAME><POSITION>Médecin adjoint</POSITION><EMAIL_1>dominique.rouiller@hcuge.ch</EMAIL_1><ADDRESS><DEPARTMENT>Division d'Endocrinologie et de Diabétologie</DEPARTMENT><ORGANISATION>Hôpitaux Universitaires de Genève</ORGANISATION><ADDRESS_1>Labo Louis Jeantet</ADDRESS_1><ADDRESS_2>CMU - Rue Michel Servet, 1</ADDRESS_2><CITY>Geneva 4</CITY><ZIP>CH-1211</ZIP><COUNTRY CODE="CH">Switzerland</COUNTRY><PHONE_1>+41 22 3823311 ext: 857916</PHONE_1></ADDRESS></PERSON><PERSON ID="5699" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Michel</FIRST_NAME><LAST_NAME>Boulvain</LAST_NAME><POSITION>Médecin adjoint agrégé</POSITION><EMAIL_1>michel.boulvain@hcuge.ch</EMAIL_1><ADDRESS><DEPARTMENT>Département de Gynécologie et d'Obstétrique, Unité de Développement en Obstétrique</DEPARTMENT><ORGANISATION>Maternité Hôpitaux Universitaires de Genève</ORGANISATION><ADDRESS_1>Boulevard de la Cluse, 32</ADDRESS_1><CITY>Genève 14</CITY><ZIP>CH-1211</ZIP><COUNTRY CODE="CH">Switzerland</COUNTRY><PHONE_1>+ 41 22 3824317</PHONE_1><FAX_1>+41 22 3824424</FAX_1><FAX_2>+41 22 3824165</FAX_2></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2009-10-28 10:10:43 +0000" MODIFIED_BY="Jill V Hampson" NOTES="&lt;p&gt;New studies found and included or excluded: 12/31/05&lt;/p&gt;" NOTES_MODIFIED="2009-10-28 10:10:43 +0000" NOTES_MODIFIED_BY="Jill V Hampson">
<UP_TO_DATE>
<DATE DAY="2" MONTH="5" YEAR="2006"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="1" MONTH="10" YEAR="2009"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="6" YEAR="2007"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2001"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2006"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2006"/>
</DATES>
<WHATS_NEW MODIFIED="2009-10-26 14:29:20 +0000" MODIFIED_BY="Jill V Hampson">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-10-26 14:29:20 +0000" MODIFIED_BY="Jill V Hampson">
<DATE DAY="1" MONTH="10" YEAR="2009"/>
<DESCRIPTION>
<P>Search updated. Six reports added to <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK> (<LINK REF="STD-Callaway-2007" TYPE="STUDY">Callaway 2007</LINK>; <LINK REF="STD-Ferrara-2008" TYPE="STUDY">Ferrara 2008</LINK>; <LINK REF="STD-Hofman-2005" TYPE="STUDY">Hofman 2005</LINK>; <LINK REF="STD-Laitinen-2009" TYPE="STUDY">Laitinen 2009</LINK>; <LINK REF="STD-Oostdam-2009" TYPE="STUDY">Oostdam 2009</LINK>; <LINK REF="STD-Shaw-2008" TYPE="STUDY">Shaw 2008</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2009-10-26 14:26:42 +0000" MODIFIED_BY="Jill V Hampson">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-10-26 14:26:42 +0000" MODIFIED_BY="Jill V Hampson">
<DATE DAY="13" MONTH="2" YEAR="2009"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-02-13 16:20:08 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2009-10-26 14:45:28 +0000" MODIFIED_BY="Jill V Hampson">
<SUMMARY MODIFIED="2008-09-02 14:04:28 +0100" MODIFIED_BY="Frances J Kellie">
<TITLE MODIFIED="2008-09-02 14:04:22 +0100" MODIFIED_BY="Frances J Kellie">Exercise for diabetic pregnant women</TITLE>
<SUMMARY_BODY MODIFIED="2008-09-02 14:04:28 +0100" MODIFIED_BY="Frances J Kellie">
<P>Insufficient information available to recommend or advise against diabetic pregnant women enrolling on exercise programs.</P>
<P>Exercise was proposed to improve glycaemic control in pregnant women with diabetes. Four small trials involving 114 pregnant women evaluated this intervention. None included pregnant women with type 1 or type 2 diabetes. There is insufficient evidence to recommend, or advise against, diabetic pregnant women enrolling in exercise programs. Further trials, with larger sample size, are needed.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2009-10-26 14:31:04 +0000" MODIFIED_BY="Jill V Hampson">
<ABS_BACKGROUND>
<P>Diabetes in pregnancy may result in unfavourable maternal and neonatal outcomes. Exercise was proposed as an additional strategy to improve glycaemic control. The effect of exercise during pregnancies complicated by diabetes needs to be assessed.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To evaluate the effect of exercise programs, alone or in conjunction with other therapies, compared to no specific program or to other therapies, in pregnant women with diabetes on perinatal and maternal morbidity and on the frequency of prescription of insulin to control glycaemia. To compare the effectiveness of different types of exercise programs on perinatal and maternal morbidity.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2009-10-26 14:29:54 +0000" MODIFIED_BY="Jill V Hampson">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 December 2005). We updated this search on 1 October 2009 and added the results to the awaiting classification section.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>All known randomised controlled trials evaluating the effect of exercise in diabetic pregnant women on perinatal outcome and maternal morbidity.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>We evaluated relevant studies for meeting the inclusion criteria and methodological quality. Three review authors abstracted the data. For all data analyses, we entered data based on the principle of intention to treat. We calculated relative risks and 95% confidence intervals for dichotomous data. </P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>Four trials, involving 114 pregnant women with gestational diabetes, were included in the review. None included pregnant women with type 1 or type 2 diabetes. Women were recruited during the third trimester and the intervention was performed for about six weeks. The programs generally consisted in exercising three times a week for 20 to 45 minutes. We found no significant difference between exercise and the other regimen in all the outcomes evaluated. </P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2009-10-26 14:31:04 +0000" MODIFIED_BY="Jill V Hampson">
<P>There is insufficient evidence to recommend, or advise against, diabetic pregnant women to enrol in exercise programs. Further trials, with larger sample size, involving women with gestational diabetes, and possibly type 1 and 2 diabetes, are needed to evaluate this intervention.</P>
<P>[Note: The six citations in the awaiting classification section of the review may alter the conclusions of the review once assessed.]</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2009-10-26 14:45:28 +0000" MODIFIED_BY="Jill V Hampson">
<BACKGROUND MODIFIED="2008-09-02 14:05:05 +0100" MODIFIED_BY="Frances J Kellie">
<P>Diabetes is a disturbance of multiple metabolic pathways, but it is the effects on carbohydrate metabolism that are most apparent. The different types of disorder of carbohydrate metabolism are all characterised by hyperglycaemia (high blood glucose level). In the short term, this can lead to coma associated with hyperglycaemia or, if there is over treatment, coma associated with hypoglycaemia (low blood glucose). Long-term complications can involve blood vessels, eyes, kidneys or the neurological system. In pregnancy, there are three types of diabetes:</P>
<OL>
<LI>insulin-dependent, or type 1 diabetes. This is diabetes beginning before pregnancy and is characterised by beta islet cell autoimmunity leading to destruction of the insulin producing cells in the pancreas.</LI>
<LI>non-insulin-dependent, or type 2 diabetes characterised by diabetes beginning before pregnancy and an inability of the pancreas to cope with a rise in insulin resistance.</LI>
<LI>gestational diabetes mellitus, defined as "carbohydrate intolerance with onset or first recognition during pregnancy" (<LINK REF="REF-Metzger-1991" TYPE="REFERENCE">Metzger 1991</LINK>). Various definitions of carbohydrate intolerance exist. There is, therefore, widespread variation in the classification of gestational diabetes. Diagnosis is generally based on an abnormal oral glucose tolerance test (GTT). A GTT requires women to fast overnight before attending the hospital the following morning. Usually, four blood samples are taken. The first is taken on arrival and the woman is then given a sugary drink containing 75 g of glucose (100 g is more commonly used in the United States). The following blood samples are taken hourly (three more samples). The precise diagnostic values of the GTT are controversial (<LINK REF="REF-Weiss-1998" TYPE="REFERENCE">Weiss 1998</LINK>) making it difficult to provide a clear definition of gestational diabetes. Values between 8 to 11 mmol/l are termed 'impaired glucose tolerance'. Current World Health Organization recommendations suggest that all abnormal glucose metabolism arising in pregnancy should be defined as gestational diabetes (<LINK REF="REF-Alberti-1998" TYPE="REFERENCE">Alberti 1998</LINK>).</LI>
</OL>
<P>In pregnancies not complicated by diabetes, the risks and benefits of exercise are still not well-known. A Cochrane review (<LINK REF="REF-Kramer-2002" TYPE="REFERENCE">Kramer 2002</LINK>) concluded that regular aerobic exercise appears to improve (or maintain) physical fitness but available data are insufficient to exclude important benefits and risks for the mother or infant. These conclusions may not apply in pregnant women with diabetes and the effect of exercise may differ according to type of diabetes.</P>
<P>Type 1 diabetes requires insulin therapy adjusted with dietary control and physical activity to achieve and maintain a normal blood glucose level. Among women with type 1 diabetes, who are not pregnant, the response to exercise is mainly influenced by the degree of diabetes control. Well-controlled diabetic women may derive benefit from regular physical activity, provided that they know how to adjust their insulin dose and carbohydrate intake (<LINK REF="REF-Berger-1977" TYPE="REFERENCE">Berger 1977</LINK>). Diabetic women with poor glycaemic control should avoid exercise because of the increased risk of hyperglycaemia, ketosis and worsening of vascular complications. During pregnancy, these women have an increased risk of fetal malformation, miscarriage, pre-eclampsia, late fetal death and macrosomia. Moreover, the risk of diabetic ketoacidosis is increased because of the less predictable effect of a given dose of insulin and an accelerated state of starvation. As ketoacidosis has been associated with high perinatal mortality (<LINK REF="REF-Lufkin-1984" TYPE="REFERENCE">Lufkin 1984</LINK>), exertion in type 1 diabetic pregnant women may increase the risk for the fetus.</P>
<P>Exercise as well as diet and weight-loss (and insulin when needed) is part of the treatment of type 2 diabetes. The effects of diet and insulin have been recently evaluated in another Cochrane review (<LINK REF="REF-Tuffnell-2003" TYPE="REFERENCE">Tuffnell 2003</LINK>). The biochemical effect of exercise (in addition to diet and insulin) in type 2 non-pregnant diabetic patients is to normalize blood glucose levels (<LINK REF="REF-Tuomilehto-2001" TYPE="REFERENCE">Tuomilehto 2001</LINK>). This suggests that during pregnancy exercise could also reduce the risk of complications related to high blood glucose and high insulin levels, including macrosomia (big baby according to his age), birth trauma, respiratory distress, neonatal hypoglycaemia and hypocalcaemia.</P>
<P>Some of the perinatal complications seen in established diabetes are also found in pregnancies with gestational diabetes. Also, some of the abnormalities of insulin secretion and action that characterize type 2 diabetes have also been identified in gestational diabetes (<LINK REF="REF-Carpenter-1995" TYPE="REFERENCE">Carpenter 1995</LINK>). This suggests that regular physical exercise may normalize maternal blood glucose for pregnant women with gestational diabetes. As the first treatment of gestational diabetes is diet, the addition of exertion may, as in type 2 diabetes, prevent the administration of insulin. This benefit may be of relevance for pregnant women reluctant to start subcutaneous insulin injection, especially when considering that the gestational diabetes generally resolves spontaneously at delivery. Indirectly, as the women who suffer from gestational diabetes are at increased risk of developing type 2 diabetes in the future, exercise may also prevent this long-term complication (<LINK REF="REF-Manson-1991" TYPE="REFERENCE">Manson 1991</LINK>; <LINK REF="REF-Tuomilehto-2001" TYPE="REFERENCE">Tuomilehto 2001</LINK>).</P>
<P>As some doctors incorporate advice about exercise during pregnancy into their management of women with gestational diabetes (<LINK REF="REF-Gabbe-2004" TYPE="REFERENCE">Gabbe 2004</LINK>), the effect of exercise during pregnancies complicated by diabetes needs to be assessed. Although transient, gestational diabetes has a deleterious effect on birth outcome. Because of the added burden that diabetes brings to the pregnancy, every effort should be made to determine the best management strategies. Additionally, a behavioural change in life style, such as diet or exercise, may persist after delivery and help prevent or delay the development of type 2 diabetes and its long-term complications (<LINK REF="REF-Tuomilehto-2001" TYPE="REFERENCE">Tuomilehto 2001</LINK>).</P>
<P>The aim of the treatment is to reduce the complications of diabetes. As improvement in blood sugar control may not be directly related to pregnancy outcome, we will not evaluate the effect of exercise on blood sugar but on its maternal and fetal complications.</P>
</BACKGROUND>
<OBJECTIVES>
<UL>
<LI>To evaluate the effect of exercise programs alone or in conjunction to other therapies such as diet, compared to no specific program or to other therapies, in diabetic pregnant women on perinatal and maternal morbidity and mortality.</LI>
<LI>To evaluate the effect of exercise programs on the frequency of prescription of insulin to control glycaemia.</LI>
<LI>To compare the effectiveness of different types of exercise programs on perinatal and maternal mortality and morbidity.</LI>
</UL>
</OBJECTIVES>
<METHODS MODIFIED="2009-10-26 14:33:33 +0000" MODIFIED_BY="Jill V Hampson">
<SELECTION_CRITERIA MODIFIED="2008-09-02 14:06:21 +0100" MODIFIED_BY="Frances J Kellie">
<CRIT_STUDIES>
<P>All known randomised controlled trials comparing any exercise program (as defined by trial authors) to no specific exercise program in diabetic pregnant women. Studies where the allocation was based on methods that are liable to selection bias ( for example, allocation by date of birth, chart number) were not included. Comparison of interrupted time series (before and after studies) were also not included. </P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Pregnant women with diabetes. A planned subgroup analysis based on the type of diabetes (that is, type 1, type 2, or gestational diabetes mellitus) was not performed because we found no study that included women with type 1 or type 2 diabetes.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Studies comparing any type of exercise program with no exercise program or other therapy. We found no studies comparing different exercise programs in pregnant women with diabetes. Type, frequency, intensity and duration of the exercise vary between studies. We have classified the various exercise programs in two categories predefined as low-level and high-level exercise programs. We have considered a cumulative duration of exercise at 50% VO2<SUB> </SUB>max (maximal oxygen consumption - being a measure of oxygen consumption and therefore of aerobic exercise) of less than 180 minutes (or equivalent intensity of exercise) as a low-level intervention, and a cumulative duration equal to or more than 180 minutes (or equivalent) as a high-level intervention. This was arbitrarily decided, but we believe that as an exercise session usually lasts thirty minutes, a cumulative duration of 180 minutes would mean at least six sessions, two or three times a week so the treatment would last at least two or three weeks. Intensity, duration and timing (gestational age at the start and stopping) of the intervention were extracted from the reports and included in the 'Characteristics of included studies' table. For gestational diabetes, most women were included during the third trimester because the diagnosis was usually made at that time. Ordinary day-to-day activity such as walking or gardening was not considered as a formal exercise program. In all the studies found, diet was part of the routine care and was similar between the intervention and the control groups.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-09-02 14:06:21 +0100" MODIFIED_BY="Frances J Kellie">
<P>The primary outcomes were caesarean section, perinatal death (death occurring during pregnancy or the first six days of life), admission and length of stay in neonatal intensive care unit.</P>
<SUBSECTION>
<HEADING LEVEL="4">Perinatal outcomes</HEADING>
<UL>
<LI>Macrosomia (usually defined as birthweight exceeding 4000 g or exceeding the 90th percentile)</LI>
<LI>Small-for-gestational age (birthweight less than the 10th percentile for gestational age)</LI>
<LI>Respiratory distress syndrome</LI>
<LI>Congenital malformations</LI>
<LI>Neonatal hypoglycaemia</LI>
<LI>Hypocalcaemia</LI>
<LI>Birth injury (shoulder dystocia, fractured clavicle, brachial plexus injury, intracranial haemorrhage)</LI>
<LI>Hyperbilirubinaemia (usually defined as bilirubinaemia exceeding 12 or 15 mg/dl)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Pregnancy complications</HEADING>
<UL>
<LI>Preterm labour (less than 37 weeks of gestation)</LI>
<LI>Hydramnios</LI>
<LI>Oligamnios</LI>
<LI>Pre-eclampsia (a disease characterized by the association of hypertension, proteinuria and oedema during pregnancy)</LI>
<LI>Hypertension</LI>
<LI>Diabetic ketoacidosis</LI>
<LI>Instrumental delivery and caesarean section</LI>
<LI>Maternal mortality</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Maternal morbidity</HEADING>
<UL>
<LI>Postoperative infection</LI>
<LI>Transfusion</LI>
<LI>Admission to intensive care unit</LI>
<LI>Use of insulin</LI>
</UL>
<UL>
<LI>Women's views on their care</LI>
</UL>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2009-10-26 14:33:33 +0000" MODIFIED_BY="Jill V Hampson">
<ELECTRONIC_SEARCHES MODIFIED="2009-10-26 14:33:33 +0000" MODIFIED_BY="Jill V Hampson">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register by contacting the Trials Search Co-ordinator (31 December 2005). We updated this search on 1 October 2009 and added the results to <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK>.</P>
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from:</P>
<OL>
<LI>quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE;</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Details of the search strategies for CENTRAL and MEDLINE, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A>.</P>
<P>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords.<BR/>
</P>
<P>We did not apply any language restrictions.</P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-09-02 14:10:36 +0100" MODIFIED_BY="Frances J Kellie">
<STUDY_SELECTION MODIFIED="2008-09-02 14:10:31 +0100" MODIFIED_BY="Frances J Kellie">
<P>Trials under consideration were evaluated according to the inclusion criteria without consideration of their results. Any disagreements were resolved by discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2008-09-02 14:10:23 +0100" MODIFIED_BY="Frances J Kellie">
<P>We have independently extracted information from the included studies. Any discrepancies were resolved by discussion. Wherever possible, missing data were sought from the authors.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2008-09-02 14:10:09 +0100" MODIFIED_BY="Frances J Kellie">
<P>Three review authors reviewed relevant studies for methodological quality.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Selection bias (randomisation and allocation concealment)</HEADING>
<P>We have assigned a quality score for each trial, using the following criteria:<BR/>(A) adequate concealment of allocation: such as telephone randomisation, consecutively numbered sealed opaque envelopes;<BR/>(B) unclear whether adequate concealment of allocation: such as list or table used, sealed envelopes, or study does not report any concealment approach;<BR/>(C) inadequate concealment of allocation: such as open list of random number tables, use of case record numbers, dates of birth or days of the week.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(2) Attrition bias (loss of participants, for example, withdrawals, dropouts, protocol deviations)</HEADING>
<P>We will assess completeness to follow up using the following criteria:<BR/>(A) less than 5% loss of participants;<BR/>(B) 5% to 9.9% loss of participants;<BR/>(C) 10% to 19.9% loss of participants;<BR/>(D) more than 20% loss of participants.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3) Performance bias (blinding of participants, researchers and outcome assessment)</HEADING>
<P>We will assess blinding using the following criteria:</P>
<OL>
<LI>blinding of participants (yes/no/unclear);</LI>
<LI>blinding of caregiver (yes/no/unclear);</LI>
<LI>blinding of outcome assessment (yes/no/unclear).</LI>
</OL>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2008-09-02 14:09:23 +0100" MODIFIED_BY="Frances J Kellie">
<P>We have carried out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2003" TYPE="REFERENCE">RevMan 2003</LINK>). We used fixed-effect meta-analysis for combining data in the absence of significant heterogeneity if trials were sufficiently similar. If heterogeneity had been found this would have been explored by sensitivity analysis followed by random-effects if required.</P>
<P>Dichotomous data: we have presented results as summary relative risk with 95% confidence intervals.<BR/>Continuous data: we have used the weighted mean difference if outcomes are measured in the same way between trials. We used the standardised mean difference to combine trials that measured the same outcome, but used different methods.</P>
</EFFECT_MEASURES>
<MISSING_DATA MODIFIED="2008-09-02 14:09:10 +0100" MODIFIED_BY="Frances J Kellie">
<P>We analysed data on all participants with available data in the group to which they were allocated, regardless of whether or not they received the allocated intervention. If in the original reports participants were not analysed in the group to which they were randomised, and there was sufficient information in the trial report, we planned to restore them to the correct group.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2008-09-02 14:08:59 +0100" MODIFIED_BY="Frances J Kellie">
<P>We have applied tests of heterogeneity between trials, when appropriate, using the I-squared statistic. When we identified high levels of heterogeneity among the trials, (exceeding 50%), we explored it, when appropriate, by prespecified subgroup analysis and planned to perform sensitivity analysis. A random-effects meta-analysis was used as an overall summary as considered appropriate.</P>
</HETEROGENEITY_ASSESSMENT>
<SUBGROUP_ANALYSIS MODIFIED="2008-09-02 14:08:45 +0100" MODIFIED_BY="Frances J Kellie">
<P>We planned to carry out the following subgroup analyses:</P>
<UL>
<LI>type of diabetes;</LI>
<LI>type of exercise program.</LI>
</UL>
<P>Only women with gestational diabetes were included. We found no study that included women with type 1 or type 2 diabetes.<BR/>As all trials were of small size, the analysis has small power to detect any difference in the effect of exercise programs.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2008-09-02 14:08:15 +0100" MODIFIED_BY="Frances J Kellie">
<P>We planned to carry out sensitivity analysis to explore the effect of trial quality assessed by concealment of allocation, by excluding studies with clearly inadequate allocation of concealment (rated C). As all four studies were rated B (unclear) and no one rated C, we did not perform a sensitivity analysis.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2009-10-26 14:45:28 +0000" MODIFIED_BY="Jill V Hampson">
<STUDY_DESCRIPTION MODIFIED="2009-10-26 14:45:28 +0000" MODIFIED_BY="Jill V Hampson">
<SUBSECTION>
<HEADING LEVEL="3">Included studies</HEADING>
<P>Four trials involving 114 women with gestational diabetes were included in the review. None of the trials included women with type 1 or type 2 diabetes mellitus. <LINK REF="STD-Jovanovic-1989" TYPE="STUDY">Jovanovic 1989</LINK> included 10 women in the exercise group and nine in the control group; <LINK REF="STD-Bung-1991" TYPE="STUDY">Bung 1991</LINK> 17 women in each group, <LINK REF="STD-Avery-1997" TYPE="STUDY">Avery 1997</LINK> 15 women in the experimental group and 14 women in the control group, and <LINK REF="STD-Brankston-2004" TYPE="STUDY">Brankston 2004</LINK> 16 women in each group. <I>See </I>
<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> for details.</P>
<P>All trials included pregnant women with gestational diabetes mellitus. Women were recruited during the third trimester of pregnancy and the intervention was performed for about six weeks. The programs consisted of exercising three to four times weekly on a cycle ergometer at 70% VO2<SUB> </SUB>max for 30 minutes (<LINK REF="STD-Avery-1997" TYPE="STUDY">Avery 1997</LINK>), in cycling for 45 minutes three times weekly at 50% VO2 max (<LINK REF="STD-Bung-1991" TYPE="STUDY">Bung 1991</LINK>), 20 minutes training on an arm ergometer three times a week (<LINK REF="STD-Jovanovic-1989" TYPE="STUDY">Jovanovic 1989</LINK>) and 30 minutes circuit type resistance training three times a week (<LINK REF="STD-Brankston-2004" TYPE="STUDY">Brankston 2004</LINK>). As all studies proposed high-level exercise programs, according to our classification, we found no study of low-level intensity. We cannot therefore compare the effect of high-level and low-level intensity programs. In all studies, women in both intervention and control group were on diet therapy.<BR/>
<BR/>Many of the outcomes prespecified for this review, especially those related to the newborn, were not reported by the authors of three of the four trials (<LINK REF="STD-Avery-1997" TYPE="STUDY">Avery 1997</LINK>; <LINK REF="STD-Brankston-2004" TYPE="STUDY">Brankston 2004</LINK>; <LINK REF="STD-Jovanovic-1989" TYPE="STUDY">Jovanovic 1989</LINK>). <LINK REF="STD-Brankston-2004" TYPE="STUDY">Brankston 2004</LINK> reported only the percentage of women receiving insulin therapy, but we are waiting for additional data. <LINK REF="STD-Bung-1991" TYPE="STUDY">Bung 1991</LINK> reported most of those outcomes, but the study is of small size. As all trials were of small size, the analysis has small power to detect any difference in the effect of exercise programs.</P>
<P>(Six reports from an updated search in October 2009 have been added to <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK>)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Excluded studies</HEADING>
<P>Three trials were excluded (<LINK REF="STD-Chen-1997" TYPE="STUDY">Chen 1997</LINK>; <LINK REF="STD-Garcia_x002d_Paterson-2001" TYPE="STUDY">Garcia-Paterson 2001</LINK>; <LINK REF="STD-Lesser-1996" TYPE="STUDY">Lesser 1996</LINK>). <I>See</I> <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> for details.</P>
</SUBSECTION>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>
<LINK REF="STD-Avery-1997" TYPE="STUDY">Avery 1997</LINK> used randomisation based on a table of random numbers arranged in blocks. No information regarding method of randomisation is given in <LINK REF="STD-Bung-1991" TYPE="STUDY">Bung 1991</LINK>. <LINK REF="STD-Jovanovic-1989" TYPE="STUDY">Jovanovic 1989</LINK>, randomised by drawing a number one or two referring to the allocation group. In all three trials, no details on the method of concealment of allocation was given.</P>
<P>
<LINK REF="STD-Bung-1991" TYPE="STUDY">Bung 1991</LINK> had a large number of exclusions, four (19%) in the exercise group and three (15%) in the insulin group. <LINK REF="STD-Brankston-2004" TYPE="STUDY">Brankston 2004</LINK> included 38 women, but six women from the exercise group were excluded because of hypertension (3) or no compliance to the intervention (3). The reported analysis includes 32 women (information on the six women excluded was sought from the authors, to be able to perform an intent-to-treat analysis). There were apparently no exclusions in the other studies.</P>
<P>The nature of the intervention did not allow blinding of the women and, probably, also blinding of the physicians.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P>Four trials involving 114 women with gestational diabetes were included in the review. None of the trials included women with type 1 or type 2 diabetes mellitus. </P>
<P>The outcomes prespecified for this review that were not reported in any of the studies are not listed in the comparison and data section. The outcome 'use of insulin therapy' was only reported by <LINK REF="STD-Avery-1997" TYPE="STUDY">Avery 1997</LINK> and <LINK REF="STD-Brankston-2004" TYPE="STUDY">Brankston 2004</LINK>, where the difference between the two groups was not significant (relative risk 0.98; 95% confidence interval 0.51 to 1.87). No woman required insulin therapy in the study by <LINK REF="STD-Jovanovic-1989" TYPE="STUDY">Jovanovic 1989</LINK>. In <LINK REF="STD-Bung-1991" TYPE="STUDY">Bung 1991</LINK>, exercise was compared to insulin treatment; therefore, this study was included in a separate analysis (diet + exercise versus diet + insulin). </P>
<P>The occurrence of macrosomia was defined in two of the trials as birthweight greater than 4000 g (<LINK REF="STD-Avery-1997" TYPE="STUDY">Avery 1997</LINK>; <LINK REF="STD-Bung-1991" TYPE="STUDY">Bung 1991</LINK>). No information was given in the third trial (<LINK REF="STD-Jovanovic-1989" TYPE="STUDY">Jovanovic 1989</LINK>). </P>
<P>We found no significant difference between exercise and no exercise and between exercise and insulin in all the outcomes evaluated.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>Many of the outcomes prespecified were not evaluated in three of the four trials (<LINK REF="STD-Avery-1997" TYPE="STUDY">Avery 1997</LINK>; <LINK REF="STD-Brankston-2004" TYPE="STUDY">Brankston 2004</LINK>; <LINK REF="STD-Jovanovic-1989" TYPE="STUDY">Jovanovic 1989</LINK>). Limited information is available regarding neonatal outcomes. Most were only evaluated in one trial (<LINK REF="STD-Bung-1991" TYPE="STUDY">Bung 1991</LINK>), giving a small sample for the analysis. We are waiting for additional data from <LINK REF="STD-Brankston-2004" TYPE="STUDY">Brankston 2004</LINK>. As, in <LINK REF="STD-Bung-1991" TYPE="STUDY">Bung 1991</LINK> insulin was an intervention and not an outcome, we analysed the results separately. We acknowledge that the outcomes we sought to evaluate are infrequent and so the power of the only study that reported them is limited. But these outcomes are those we try to prevent when treating pregnant women with diabetes; it is thus important to evaluate the effects of exercise on these clinically relevant outcomes. Only one report described the methods used for concealment of allocation (<LINK REF="STD-Brankston-2004" TYPE="STUDY">Brankston 2004</LINK>). <BR/> <BR/>Only women with gestational diabetes were included. We found no study that included women with type 1 or type 2 diabetes. The effect of exercise may be similar in women with type 2 and gestational diabetes, but may be different in women with type 1 diabetes. Exercise in pregnant women with type 1 diabetes may be harmful because of the increased risk of ketoacidosis, thus it may not be safe to initiate a trial in that subgroup of pregnant women. It would be important that further studies of larger sample size involving pregnant women with type 2 and gestational diabetes be initiated, given that some clinicians include exercise in their management of women with gestational diabetes without evidence that this is beneficial.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2009-10-26 14:37:16 +0000" MODIFIED_BY="Jill V Hampson">
<IMPLICATIONS_PRACTICE>
<P>There is insufficient evidence to recommend, or advise against, diabetic pregnant women enrolling in exercise programs. Even if exercise is not beneficial during pregnancy, this change in life style may persist after delivery and may help prevent the onset of type 2 diabetes and its long-term complications. Therefore, women may enrol in exercise programs, if they wish to do so. </P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2009-10-26 14:37:16 +0000" MODIFIED_BY="Jill V Hampson">
<P>Further trials with larger sample sizes involving women with gestational diabetes, and possibly type 2 diabetes, are needed to evaluate this intervention. A useful, relevant and relatively frequent outcome measure may be 'use of insulin'. Researchers, however, must be aware of a potential bias in the prescription of insulin, given the impossibility to blind caregivers as to the group allocation in this context.</P>
<P>[Note: The six citations in the awaiting classification section of the review may alter the conclusions of the review once assessed.]</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>As part of the pre-publication editorial process, this review has been commented on by three peers (an editor and two referees who are external to the editorial team), one or more members of the Pregnancy and Childbirth Group's international panel of consumers and the Group's Statistical Adviser.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>All three review authors wrote the protocol. Gilles Ceysens and Michel Boulvain searched for the trials, assessed the trials to be included, and extracted the data. All three authors analyzed the results and wrote the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2009-10-26 14:28:16 +0000" MODIFIED_BY="Jill V Hampson">
<STUDIES MODIFIED="2009-10-26 14:28:16 +0000" MODIFIED_BY="Jill V Hampson">
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Avery-1997" NAME="Avery 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Avery MD, Leon AS, Kopher RA</AU>
<TI>Effects of a partially home-based exercise program for women with gestational diabetes</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1997</YR>
<VL>89</VL>
<NO>1</NO>
<PG>10-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brankston-2004" NAME="Brankston 2004" YEAR="2004">
<REFERENCE NOTES="&lt;p&gt;Brankston GN, Mitchell BF, Ryan EA, Okun NB. Resistance exercise decreases the need for insulin in overweight women with gestational diabetes mellitus. American Journal of Obstetrics &amp;amp; Gynecology 2004;190(1):188-93&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brankston GN, Mitchell BF, Ryan EA, Okun NB</AU>
<TI>Resistance exercise decreases the need for insulin in overweight women with gestational diabetes mellitus</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2004</YR>
<VL>190</VL>
<NO>1</NO>
<PG>188-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bung-1991" NAME="Bung 1991" YEAR="1991">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bung P, Artal R, Khodiguian N, Kjos S</AU>
<TI>Exercise in gestational diabetes an optional therapeutic approach?</TI>
<SO>Diabetes</SO>
<YR>1991</YR>
<VL>40</VL>
<NO>Suppl 2</NO>
<PG>182-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bung P, Artal R, Khodiguian N</AU>
<TI>Regular exercise therapy in disturbed carbohydrate metabolism during pregnancy - results of a prospective randomised longitudinal study</TI>
<SO>Geburtshilfe und Frauenheilkunde</SO>
<YR>1993</YR>
<VL>53</VL>
<PG>188-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bung P, Bung C, Artal R, Khodiguian N, Fallenstein F, Spatling L</AU>
<TI>Therapeutic exercise for insulin-requiring gestational diabetics: effects on the fetus--results of a randomized prospective longitudinal study</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>1993</YR>
<VL>21</VL>
<NO>2</NO>
<PG>125-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jovanovic-1989" NAME="Jovanovic 1989" YEAR="1989">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Jovanovic-Peterson L, Durak EP, Peterson CM</AU>
<TI>Randomized trial of diet vesus diet plus cardiovascular conditioning on glucose levels in gestational diabetes</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1989</YR>
<VL>161</VL>
<PG>415-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jovanovic-Peterson L, Peterson CM</AU>
<TI>Is exercise safe or useful for gestational diabetic women?</TI>
<SO>Diabetes</SO>
<YR>1991</YR>
<VL>40</VL>
<NO>Suppl 2</NO>
<PG>179-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-1997" NAME="Chen 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Chen B, Steiner J, Holcomb W. Effects of a short-term moderate exercise program on glucose tolerance in pregnancy . American Journal of Obstetrics and Gynecology 1997;176(1 Pt 2):S173&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen B, Steiner J, Holcomb W</AU>
<TI>Effects of a short-term moderate exercise program on glucose tolerance in pregnancy</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1997</YR>
<VL>176</VL>
<NO>1 Pt 2</NO>
<PG>S173</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garcia_x002d_Paterson-2001" NAME="Garcia-Paterson 2001" YEAR="2001">
<REFERENCE NOTES="&lt;p&gt;Garcia-Patterson A, Martin E, Ubeda J, Maria MA, de Leiva A, Corcoy R. Evaluation of light exercise in the treatment of gestational diabetes. Diabetes Care 2001;24:2006-7&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garcia-Patterson A, Martin E, Ubeda J, Maria MA, de Leiva A, Corcoy R</AU>
<TI>Evaluation of light exercise in the treatment of gestational diabetes</TI>
<SO>Diabetes Care</SO>
<YR>2001</YR>
<VL>24</VL>
<PG>2006-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lesser-1996" NAME="Lesser 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lesser KB, Gruppuso PA, Terry RB, Carpenter MW</AU>
<TI>Exercise fails to improve postprandial glycemic excursion in women with gestational diabetes</TI>
<SO>Journal of Maternal-Fetal Medicine</SO>
<YR>1996</YR>
<VL>5</VL>
<PG>211-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2009-10-26 14:28:16 +0000" MODIFIED_BY="Jill V Hampson">
<STUDY DATA_SOURCE="PUB" ID="STD-Callaway-2007" MODIFIED="2009-10-26 14:27:58 +0000" MODIFIED_BY="Jill V Hampson" NAME="Callaway 2007" YEAR="(accessed 21 June 2007)">
<REFERENCE MODIFIED="2009-10-26 14:27:58 +0000" MODIFIED_BY="Jill V Hampson" PRIMARY="NO" TYPE="OTHER">
<AU>Callaway L</AU>
<TI>A randomized controlled trial using exercise to reduce gestational diabetes and other adverse maternal and neonatal outcomes in obese pregnant women - the pilot study</TI>
<SO>Australian Clinical Trials Registry (www.actr.org.au)</SO>
<YR>(accessed 21 June 2007)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ferrara-2008" MODIFIED="2009-10-26 14:28:01 +0000" MODIFIED_BY="Jill V Hampson" NAME="Ferrara 2008" YEAR="(accessed 20 February 2008)">
<REFERENCE MODIFIED="2009-10-26 14:28:01 +0000" MODIFIED_BY="Jill V Hampson" PRIMARY="NO" TYPE="OTHER">
<AU>Ferrara A</AU>
<TI>Diet, exercise and breastfeeding intervention program for women with gestational diabetes (DEBI Trial)</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/)</SO>
<YR>(accessed 20 February 2008)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hofman-2005" MODIFIED="2009-10-26 14:28:08 +0000" MODIFIED_BY="Jill V Hampson" NAME="Hofman 2005" YEAR="(accessed 6 December 2005)">
<REFERENCE MODIFIED="2009-10-26 14:28:08 +0000" MODIFIED_BY="Jill V Hampson" PRIMARY="NO" TYPE="OTHER">
<AU>Hofman P, Hopkins S</AU>
<TI>Randomised controlled study of the effects of exercise during pregnancy on maternal insulin sensitivity and neonatal outcomes</TI>
<SO>Australian Clinical Trials Register (http://www.actr.org/actr)</SO>
<YR>(accessed 6 December 2005)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laitinen-2009" MODIFIED="2009-10-26 14:28:10 +0000" MODIFIED_BY="Jill V Hampson" NAME="Laitinen 2009" YEAR="2009">
<REFERENCE MODIFIED="2009-10-26 14:28:10 +0000" MODIFIED_BY="Jill V Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laitinen K, Poussa T, Isolauri E, the Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota Group</AU>
<TI>Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial</TI>
<SO>British Journal of Nutrition</SO>
<YR>2009</YR>
<VL>101</VL>
<NO>11</NO>
<PG>1679-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oostdam-2009" MODIFIED="2009-10-26 14:28:13 +0000" MODIFIED_BY="Jill V Hampson" NAME="Oostdam 2009" YEAR="2009">
<REFERENCE MODIFIED="2009-10-26 14:28:13 +0000" MODIFIED_BY="Jill V Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oostdam N, van Poppel MN, Eekhoff EM, Wouters MG, van Mechelen W</AU>
<TI>Design of FitFor2 study: the effects of an exercise program on insulin sensitivity and plasma glucose levels in pregnant women at high risk for gestational diabetes</TI>
<SO>BMC Pregnancy and Childbirth</SO>
<YR>2009</YR>
<VL>9</VL>
<PG>1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shaw-2008" MODIFIED="2009-10-26 14:28:16 +0000" MODIFIED_BY="Jill V Hampson" NAME="Shaw 2008" YEAR="(accessed 19 February 2008)">
<REFERENCE MODIFIED="2009-10-26 14:28:16 +0000" MODIFIED_BY="Jill V Hampson" PRIMARY="NO" TYPE="OTHER">
<AU>Shaw J</AU>
<TI>The efficacy and feasibility of progressive strength training in the management of glucose control in women with gestational diabetes</TI>
<SO>Australian New Zealand Clinical Trials Registry (www.anzctr.org.au)</SO>
<YR>(accessed 19 February 2008)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2009-10-26 14:28:16 +0000" MODIFIED_BY="Jill V Hampson">
<ADDITIONAL_REFERENCES>
<REFERENCE ID="REF-Alberti-1998" NAME="Alberti 1998" TYPE="JOURNAL_ARTICLE">
<AU>Alberti K, Zimmet PZ</AU>
<TI>Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation</TI>
<SO>Diabetic Medicine</SO>
<YR>1998</YR>
<VL>15</VL>
<PG>539-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Berger-1977" NAME="Berger 1977" TYPE="JOURNAL_ARTICLE">
<AU>Berger M, Berchtold P, Cuppers JH, Drost H, Kley HK, Muller WA et al</AU>
<TI>Metabolic and hormonal effects of muscular exercise in juvenile type diabetics</TI>
<SO>Diabetologia</SO>
<YR>1977</YR>
<VL>13</VL>
<NO>4</NO>
<PG>355-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carpenter-1995" NAME="Carpenter 1995" TYPE="BOOK_SECTION">
<AU>Carpenter MW</AU>
<TI>Exercise in normal and diabetic pregnancies</TI>
<SO>Diabetes mellitus in pregnancy</SO>
<YR>1995</YR>
<PG>201-18</PG>
<ED>Reece EA, Coustan DR</ED>
<PB>Churchill Livingstone</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gabbe-2004" NAME="Gabbe 2004" TYPE="JOURNAL_ARTICLE">
<AU>Gabbe SG, Gregory RP, Power ML, Williams SB, Schulkin J</AU>
<TI>Management of diabetes mellitus by obstetricians-gynecologists</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2004</YR>
<VL>103</VL>
<NO>6</NO>
<PG>1229-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kramer-2002" NAME="Kramer 2002" TYPE="COCHRANE_REVIEW">
<AU>Kramer MS</AU>
<TI>Aerobic exercise for women during pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>2</NO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lufkin-1984" NAME="Lufkin 1984" TYPE="JOURNAL_ARTICLE">
<AU>Lufkin EG, Nelson RL, Hill LM, Melton LJ 3rd, O'Fallon WM, Evans AT 3rd</AU>
<TI>An analysis of diabetic pregnancies at Mayo Clinic, 1950-79</TI>
<SO>Diabetes Care</SO>
<YR>1984</YR>
<VL>7</VL>
<NO>6</NO>
<PG>539-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Manson-1991" NAME="Manson 1991" TYPE="JOURNAL_ARTICLE">
<AU>Manson JE, Rimm EB, Stampfer MJ, Colditz GA, Willett WC, Krolewski AS et al</AU>
<TI>Physical activity and incidence of non-insulin-dependent diabetes mellitus in women</TI>
<SO>Lancet</SO>
<YR>1991</YR>
<VL>338</VL>
<NO>8770</NO>
<PG>774-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Metzger-1991" NAME="Metzger 1991" TYPE="JOURNAL_ARTICLE">
<AU>Metzger BE</AU>
<TI>Summary and recommendations of the Third International Workshop-Conference on Gestational Diabetes Mellitus</TI>
<SO>Diabetes</SO>
<YR>1991</YR>
<VL>40</VL>
<NO>Suppl 2</NO>
<PG>197-201</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2003" NAME="RevMan 2003" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2003</YR>
<EN>4.2 for Windows</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<MD>CD-ROM and Internet</MD>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tuffnell-2003" NAME="Tuffnell 2003" TYPE="COCHRANE_REVIEW">
<AU>Tuffnell DJ, West J, Walkinshaw SA</AU>
<TI>Treatments for gestational diabetes and impaired glucose tolerance in pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>3</NO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tuomilehto-2001" NAME="Tuomilehto 2001" TYPE="JOURNAL_ARTICLE">
<AU>Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al</AU>
<TI>Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance</TI>
<SO>New England Journal of Medicine</SO>
<YR>2001</YR>
<VL>344</VL>
<NO>18</NO>
<PG>1343-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weiss-1998" NAME="Weiss 1998" TYPE="JOURNAL_ARTICLE">
<AU>Weiss PA, Hausler M, Kainer F, Purstner P, Haas J</AU>
<TI>Toward universal criteria for gestational diabetes: relationships between capillary and venous glucose concentrations</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1998</YR>
<VL>178</VL>
<NO>4</NO>
<PG>830-5</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2009-10-26 14:28:16 +0000" MODIFIED_BY="Jill V Hampson"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2009-10-26 14:28:16 +0000" MODIFIED_BY="Jill V Hampson">
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Avery-1997">
<CHAR_METHODS>
<P>Randomisation: table of random numbers arranged in blocks. <BR/>Concealment of allocation: no details.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>29 women at 34 weeks' gestation, or less, with gestational diabetes mellitus.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Experimental (n = 15): 30 min exercise 3-4 x/week + supervised exercise on cycle ergometer at 70% VO2 max 2 x/week + unsupervised 30 min exercise by cycling or walking at same exercise intensity.<BR/>Control (n = 14): usual physical activity. <BR/>Women in both groups were given dietary advice.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Women: hypertension, caesarean section, use of insulin therapy, mean haemoglobin A1C at four weeks.<BR/>Babies: gestational age at delivery, premature delivery, stillbirth, neonatal death, macrosomia, birthweight, 5 minute Apgar &lt; 7.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Classified as high-level exercise program (the cumulative time of exercise at minimum 50% VO2max exceed 180 minutes).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Brankston-2004">
<CHAR_METHODS>
<P>Randomisation: table of random numbers.<BR/>Concealment of allocation: opaque sealed envelopes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>38 women at 26 to 32 weeks' gestation, with gestational diabetes mellitus.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Experimental (n = 16): 3 sessions of a circuit of 8 exercises repeated until felt "somewhat hard". Control (n = 16): asked not to start a specific exercise program. Women in both groups were given dietary advice.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Use of insulin therapy.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Additional information requested.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Bung-1991">
<CHAR_METHODS>
<P>No details on the method of randomisation nor on the method of concealment of allocation.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>34 pregnant women, at less than 33 weeks of gestation, with gestational diabetes mellitus.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Experimental group n = 17: diet (30 kcal/kg/day) and cycling for 45 minutes, three times a week, at 50% VO2 max (17 women). <BR/>Control group n = 17: diet (30 kcal/kg/day) and insulin therapy (17 women).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Gestational age at delivery, premature delivery, stillbirth, neonatal death, macrosomia, birthweight, small for date, respiratory distress syndrome, congenital malformation, 5 minute Apgar &lt; 7, neonatal hypoglycaemia, preterm labour, induction of labour, caesarean section, instrumental delivery, use of insulin therapy.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Bung 1993 is just another citation to the included study (Bung 1991) and the outcomes were related to glycemic control rather than clinical outcomes.<BR/>Classified as high-level exercise program (the cumulative time of exercise at minimum 50% VO2max exceed 180 minutes).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Jovanovic-1989">
<CHAR_METHODS>
<P>Randomisation by drawing a number (1 or 2). No details on the method of concealment of allocation.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>19 pregnant women with gestational diabetes mellitus.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Experimental group n = 10: 6 week program of dietary therapy of 24 to 30 kcal/kg/day (40% carbohydrates, 20% protein and 40% fat) and 20 minutes training on an arm ergometer, three times a week (10 women).<BR/>Control group (n = 9): same diet but no exercise.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Gestational age at delivery, premature delivery, stillbirth, neonatal death, birthweight, use of insulin therapy, response to the glucose challenge test (plasma glucose level 1 hour after 50 g oral glucose) after the training program, fasting plasma glucose after the training program.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Classified as high-level exercise program (the cumulative time of exercise at minimum 50% VO2max exceed 180 minutes).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>min: minutes<BR/>RCT: randomised controlled trial<BR/>VO2max: maximal oxygen consumption</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Chen-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>9 women; 4 with exercise and 5 without. No clinical outcome is reported, only the area under the glucose curve.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Garcia_x002d_Paterson-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>20 women; cross-over trial comparing glucose measurements during one day with light post-prandial exercise with those of one day without exercise; no clinical outcome reported, not possible anyway with this design.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lesser-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>The study evaluates the effect of a single exercise session (30 minutes cycling at 60% VO2 max) on fasting glycaemia and insulin concentration and glycaemic and insulin excursion following a mixed nutrient meal in women with gestational diabetes secondary to a postexertional increase in insulin sensitivity. The authors did not evaluate the effect of chronic exercise on any of the outcomes we specified.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>VO2 max: maximal oxygen consumption</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2009-10-26 14:28:16 +0000" MODIFIED_BY="Jill V Hampson" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR STUDY_ID="STD-Callaway-2007">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Ferrara-2008">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Hofman-2005">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Laitinen-2009">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Oostdam-2009">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Shaw-2008">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Avery-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Brankston-2004">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bung-1991">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jovanovic-1989">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Exercise and diet versus diet alone</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.46878857858019785" CI_START="-1.0687885785802065" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.30000000000000426" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.44437540057390823" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="14" UNITS="" WEIGHT="100.0" Z="0.7648256123262425">
<NAME>Gestational age at delivery</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.46878857858019785" CI_START="-1.0687885785802065" EFFECT_SIZE="-0.30000000000000426" ESTIMABLE="YES" MEAN_1="39.4" MEAN_2="39.7" ORDER="52689" SD_1="1.2" SD_2="0.9" SE="0.39224627832159586" STUDY_ID="STD-Avery-1997" TOTAL_1="15" TOTAL_2="14" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="23" WEIGHT="0.0" Z="0.0">
<NAME>Preterm delivery (&lt; 37 weeks)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="52690" O_E="0.0" SE="0.0" STUDY_ID="STD-Avery-1997" TOTAL_1="15" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="52691" O_E="0.0" SE="0.0" STUDY_ID="STD-Jovanovic-1989" TOTAL_1="10" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.094672280491008" CI_END="1.8700582364967768" CI_START="0.5149391495556646" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9813084112149534" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" I2="8.648458737672927" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.27185513134686196" LOG_CI_START="-0.288244088577405" LOG_EFFECT_SIZE="-0.00819447861527152" METHOD="MH" NO="3" P_CHI2="0.2954387756846544" P_Q="0.0" P_Z="0.9542662840262442" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="41" TOTAL_2="39" WEIGHT="100.00000000000001" Z="0.05735013507138068">
<NAME>Use of insulin therapy</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.647958068340985" CI_START="0.40292106147005136" EFFECT_SIZE="1.8666666666666667" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.9369135751714014" LOG_CI_START="-0.39478003059832545" LOG_EFFECT_SIZE="0.27106677228653797" ORDER="52692" O_E="0.0" SE="0.7822434160188003" STUDY_ID="STD-Avery-1997" TOTAL_1="15" TOTAL_2="14" VAR="0.611904761904762" WEIGHT="18.691588785046733"/>
<DICH_DATA CI_END="1.5723177172774938" CI_START="0.38474302296383434" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.19654030819093726" LOG_CI_START="-0.41482924704107327" LOG_EFFECT_SIZE="-0.10914446942506803" ORDER="52693" O_E="0.0" SE="0.3591215030713894" STUDY_ID="STD-Brankston-2004" TOTAL_1="16" TOTAL_2="16" VAR="0.12896825396825395" WEIGHT="81.30841121495328"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="52694" O_E="0.0" SE="0.0" STUDY_ID="STD-Jovanovic-1989" TOTAL_1="10" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.880477204887019" CI_START="0.2244855632740339" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9333333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.5888851366007624" LOG_CI_START="-0.6488115833556488" LOG_EFFECT_SIZE="-0.02996322337744321" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.9243966575708894" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="14" WEIGHT="100.0" Z="0.09489697715703006">
<NAME>Caesarean section</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.880477204887019" CI_START="0.2244855632740339" EFFECT_SIZE="0.9333333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.5888851366007624" LOG_CI_START="-0.6488115833556488" LOG_EFFECT_SIZE="-0.02996322337744321" ORDER="52695" O_E="0.0" SE="0.7270291799999699" STUDY_ID="STD-Avery-1997" TOTAL_1="15" TOTAL_2="14" VAR="0.5285714285714286" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="2.3522215441628385" CI_END="352.44557131555274" CI_START="-349.6317542752733" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="1.4069085201397082" ESTIMABLE="YES" I2="57.48699766475855" I2_Q="0.0" ID="CMP-001.05" NO="5" P_CHI2="0.12510476726431863" P_Q="1.0" P_Z="0.9937324963667394" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="37044.908730158735" TOTALS="YES" TOTAL_1="25" TOTAL_2="23" UNITS="" WEIGHT="100.0" Z="0.00785523169173947">
<NAME>Birthweight at delivery</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="158.797447506688" CI_START="-538.7974475066881" EFFECT_SIZE="-190.0" ESTIMABLE="YES" MEAN_1="3419.0" MEAN_2="3609.0" ORDER="52696" SD_1="528.0" SD_2="428.0" SE="177.9611514588828" STUDY_ID="STD-Avery-1997" TOTAL_1="15" TOTAL_2="14" WEIGHT="46.68331238993323"/>
<CONT_DATA CI_END="467.0241803547905" CI_START="-129.02418035479047" EFFECT_SIZE="169.0" ESTIMABLE="YES" MEAN_1="3634.0" MEAN_2="3465.0" ORDER="52697" SD_1="317.0" SD_2="343.0" SE="152.05594730595416" STUDY_ID="STD-Jovanovic-1989" TOTAL_1="10" TOTAL_2="9" WEIGHT="53.31668761006677"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.880477204887019" CI_START="0.2244855632740339" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9333333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.5888851366007624" LOG_CI_START="-0.6488115833556488" LOG_EFFECT_SIZE="-0.02996322337744321" METHOD="MH" NO="6" P_CHI2="1.0" P_Q="0.0" P_Z="0.9243966575708894" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="14" WEIGHT="100.0" Z="0.09489697715703006">
<NAME>Macrosomia (&gt; 4000 g)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.880477204887019" CI_START="0.2244855632740339" EFFECT_SIZE="0.9333333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.5888851366007624" LOG_CI_START="-0.6488115833556488" LOG_EFFECT_SIZE="-0.02996322337744321" ORDER="52698" O_E="0.0" SE="0.7270291799999699" STUDY_ID="STD-Avery-1997" TOTAL_1="15" TOTAL_2="14" VAR="0.5285714285714286" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>Apgar &lt; 7 at 5 minutes</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="52699" O_E="0.0" SE="0.0" STUDY_ID="STD-Avery-1997" TOTAL_1="15" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="23" WEIGHT="0.0" Z="0.0">
<NAME>Stillbirth</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="52700" O_E="0.0" SE="0.0" STUDY_ID="STD-Avery-1997" TOTAL_1="15" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="52701" O_E="0.0" SE="0.0" STUDY_ID="STD-Jovanovic-1989" TOTAL_1="10" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Diet + exercise versus diet + insulin (not prespecified)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.9477662694634466" CI_START="-0.5477662694634551" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.6999999999999957" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.2715305648139643" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" UNITS="" WEIGHT="100.0" Z="1.0995447006016514">
<NAME>Gestational age at delivery</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.9477662694634466" CI_START="-0.5477662694634551" EFFECT_SIZE="0.6999999999999957" ESTIMABLE="YES" MEAN_1="38.9" MEAN_2="38.2" ORDER="52702" SD_1="1.7" SD_2="2.0" SE="0.6366271417769265" STUDY_ID="STD-Bung-1991" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="5.009074665946237" CI_START="0.04990941774128532" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.6997575053902041" LOG_CI_START="-1.3018174967181666" LOG_EFFECT_SIZE="-0.3010299956639812" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.5554966203199421" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0" Z="0.5895436834954109">
<NAME>Preterm delivery (&lt; 37 weeks)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.009074665946237" CI_START="0.04990941774128532" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6997575053902041" LOG_CI_START="-1.3018174967181666" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="52703" O_E="0.0" SE="1.1757350641945108" STUDY_ID="STD-Bung-1991" TOTAL_1="17" TOTAL_2="17" VAR="1.3823529411764706" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="6.303251334775796" CI_START="0.15864828274939313" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.7995646244554626" LOG_CI_START="-0.7995646244554626" LOG_EFFECT_SIZE="0.0" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0" Z="0.0">
<NAME>Preterm labour</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="6.303251334775796" CI_START="0.15864828274939313" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7995646244554626" LOG_CI_START="-0.7995646244554626" LOG_EFFECT_SIZE="0.0" ORDER="52704" O_E="0.0" SE="0.9393364366277243" STUDY_ID="STD-Bung-1991" TOTAL_1="17" TOTAL_2="17" VAR="0.8823529411764706" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="5.009074665946237" CI_START="0.04990941774128532" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.6997575053902041" LOG_CI_START="-1.3018174967181666" LOG_EFFECT_SIZE="-0.3010299956639812" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.5554966203199421" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0" Z="0.5895436834954109">
<NAME>Induction of labour</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.009074665946237" CI_START="0.04990941774128532" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6997575053902041" LOG_CI_START="-1.3018174967181666" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="52705" O_E="0.0" SE="1.1757350641945108" STUDY_ID="STD-Bung-1991" TOTAL_1="17" TOTAL_2="17" VAR="1.3823529411764706" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.4995346037782276" CI_START="0.12700101435333877" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="0.544010292221669" LOG_CI_START="-0.8961928103330314" LOG_EFFECT_SIZE="-0.17609125905568127" METHOD="MH" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="0.6317372232317933" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0" Z="0.47928313045463594">
<NAME>Caesarean section</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.4995346037782267" CI_START="0.12700101435333883" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5440102922216687" LOG_CI_START="-0.8961928103330312" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="52706" O_E="0.0" SE="0.8459824315609655" STUDY_ID="STD-Bung-1991" TOTAL_1="17" TOTAL_2="17" VAR="0.7156862745098038" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.8798875080962683" CI_START="0.010309577253601012" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="0.5888191340165583" LOG_CI_START="-1.9867591426885958" LOG_EFFECT_SIZE="-0.6989700043360187" METHOD="MH" NO="6" P_CHI2="1.0" P_Q="0.0" P_Z="0.2874172339006107" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0" Z="1.0638046198502176">
<NAME>Instrumental delivery</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.87988750809627" CI_START="0.010309577253601012" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5888191340165585" LOG_CI_START="-1.9867591426885958" LOG_EFFECT_SIZE="-0.6989700043360187" ORDER="52707" O_E="0.0" SE="1.5129074290546958" STUDY_ID="STD-Bung-1991" TOTAL_1="17" TOTAL_2="17" VAR="2.288888888888889" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="235.39784730577406" CI_START="-461.39784730577406" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-113.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.07" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.5249730678211425" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" UNITS="" WEIGHT="100.0" Z="0.6356983315647358">
<NAME>Birthweight at delivery</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="235.39784730577406" CI_START="-461.39784730577406" EFFECT_SIZE="-113.0" ESTIMABLE="YES" MEAN_1="3369.0" MEAN_2="3482.0" ORDER="52708" SD_1="534.0" SD_2="502.0" SE="177.7572700589867" STUDY_ID="STD-Bung-1991" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.3760237133777258" CI_START="0.10521780510540575" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-002.08" LOG_CI_END="0.3758507707105457" LOG_CI_START="-0.977910762038508" LOG_EFFECT_SIZE="-0.3010299956639812" METHOD="MH" NO="8" P_CHI2="1.0" P_Q="0.0" P_Z="0.3833954603031223" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0" Z="0.8716571353147192">
<NAME>Macrosomia (&gt; 4000 g)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.3760237133777258" CI_START="0.10521780510540575" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3758507707105457" LOG_CI_START="-0.977910762038508" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="52709" O_E="0.0" SE="0.7952062255644573" STUDY_ID="STD-Bung-1991" TOTAL_1="17" TOTAL_2="17" VAR="0.6323529411764706" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" WEIGHT="0.0" Z="0.0">
<NAME>Small-for-gestational age</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="52710" O_E="0.0" SE="0.0" STUDY_ID="STD-Bung-1991" TOTAL_1="17" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="20.03629866378495" CI_START="0.19963767096514132" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.10" LOG_CI_END="1.3018174967181666" LOG_CI_START="-0.6997575053902041" LOG_EFFECT_SIZE="0.3010299956639812" METHOD="MH" NO="10" P_CHI2="1.0" P_Q="0.0" P_Z="0.5554966203199421" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0" Z="0.5895436834954109">
<NAME>Neonatal hypoglycaemia</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="20.03629866378495" CI_START="0.19963767096514132" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3018174967181666" LOG_CI_START="-0.6997575053902041" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="52711" O_E="0.0" SE="1.1757350641945108" STUDY_ID="STD-Bung-1991" TOTAL_1="17" TOTAL_2="17" VAR="1.3823529411764706" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="7.649243330266568" CI_START="0.01452576500886906" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.11" LOG_CI_END="0.8836184764944177" LOG_CI_START="-1.8378609859337425" LOG_EFFECT_SIZE="-0.4771212547196625" METHOD="MH" NO="11" P_CHI2="1.0" P_Q="0.0" P_Z="0.4919381264121142" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0" Z="0.6872294929425984">
<NAME>Apgar &lt; 7 at 5 minutes</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.649243330266568" CI_START="0.01452576500886906" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8836184764944177" LOG_CI_START="-1.8378609859337425" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="52712" O_E="0.0" SE="1.5986105077709065" STUDY_ID="STD-Bung-1991" TOTAL_1="17" TOTAL_2="17" VAR="2.555555555555556" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.12" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="12" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" WEIGHT="0.0" Z="0.0">
<NAME>Stillbirth</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="52713" O_E="0.0" SE="0.0" STUDY_ID="STD-Bung-1991" TOTAL_1="17" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="7.649243330266568" CI_START="0.01452576500886906" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.13" LOG_CI_END="0.8836184764944177" LOG_CI_START="-1.8378609859337425" LOG_EFFECT_SIZE="-0.4771212547196625" METHOD="MH" NO="13" P_CHI2="1.0" P_Q="0.0" P_Z="0.4919381264121142" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0" Z="0.6872294929425984">
<NAME>Congenital malformation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.649243330266568" CI_START="0.01452576500886906" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8836184764944177" LOG_CI_START="-1.8378609859337425" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="52714" O_E="0.0" SE="1.5986105077709065" STUDY_ID="STD-Bung-1991" TOTAL_1="17" TOTAL_2="17" VAR="2.555555555555556" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>